Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2002 4
2003 4
2004 4
2005 2
2006 1
2008 1
2009 1
2010 2
2011 3
2012 3
2013 6
2014 7
2015 5
2016 3
2017 2
2018 1
2019 3
2020 3
2021 1
2022 3
2023 4
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Cost-effectiveness of ocular interventions.
Busbee BG, Brown GC, Brown MM. Busbee BG, et al. Curr Opin Ophthalmol. 2003 Jun;14(3):132-8. doi: 10.1097/00055735-200306000-00004. Curr Opin Ophthalmol. 2003. PMID: 12777931 Review.
Overview of ocular anesthesia: past and present.
Bryant JS, Busbee BG, Reichel E. Bryant JS, et al. Among authors: busbee bg. Curr Opin Ophthalmol. 2011 May;22(3):180-4. doi: 10.1097/ICU.0b013e328345974c. Curr Opin Ophthalmol. 2011. PMID: 21427572 Review.
Alternative medicines as emerging therapies for inflammatory bowel diseases.
Singh UP, Singh NP, Busbee B, Guan H, Singh B, Price RL, Taub DD, Mishra MK, Nagarkatti M, Nagarkatti PS. Singh UP, et al. Among authors: busbee b. Int Rev Immunol. 2012 Feb;31(1):66-84. doi: 10.3109/08830185.2011.642909. Int Rev Immunol. 2012. PMID: 22251008 Free PMC article. Review.
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study.
Khanani AM, Boyer DS, Wykoff CC, Regillo CD, Busbee BG, Pieramici D, Danzig CJ, Joondeph BC, Major JC Jr, Turpcu A, Kiss S. Khanani AM, et al. Among authors: busbee bg. EClinicalMedicine. 2023 Dec 22;67:102394. doi: 10.1016/j.eclinm.2023.102394. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38152412 Free PMC article.
Our advances are fabulous. Then what is the problem?
Brown GC, Busbee BG. Brown GC, et al. Among authors: busbee bg. Curr Opin Ophthalmol. 2014 May;25(3):155-7. doi: 10.1097/ICU.0000000000000053. Curr Opin Ophthalmol. 2014. PMID: 24675285 No abstract available.
61 results